Research Article
Human Adult Stem Cells Maintain a Constant Phenotype Profile Irrespective of Their Origin, Basal Media, and Long Term Cultures
Table 1
Comparative analysis of ranges of marker expression profile.
| | MARKERS | PASSAGE | OF | SF | BM | | LG | MEM | F12 | KO | LG | MEM | F12 | KO | LG | MEM | F12 | KO |
| | ALDH | EARLY | L | L | M | L | L | L | L | L | L | L | L | L | | LATE | L | L | M | L | L | L | L | L | L | L | L | L | | CD29 | EARLY | R | R | R | R | R | R | R | R | R | R | R | R | | LATE | R | R | R | R | R | R | R | R | R | R | R | R | | CD90 | EARLY | R | R | R | R | R | R | R | R | R | R | R | R | | LATE | R | R | R | R | R | R | R | R | R | R | R | R | | CD105 | EARLY | R | R | R | R | R | R | R | R | R | R | R | R | | LATE | R | R | R | R | R | R | R | R | R | R | R | R | | SSEA4 | EARLY | S | S | S | S | L | S | S | S | L | S | S | S | | LATE | L | S | S | S | L | S | S | S | L | L | S | S | | CD34 | EARLY | S | S | L | S | S | S | S | S | S | S | S | S | | LATE | S | S | S | S | S | S | S | S | S | S | S | S | | CD45 | EARLY | S | S | L | S | S | S | S | S | S | S | S | S | | LATE | S | S | S | S | S | S | S | S | S | S | S | S | | CD133 | EARLY | S | S | S | S | S | S | S | S | S | S | S | S | | LATE | S | S | S | S | S | S | S | S | S | S | S | S | | CD31 | EARLY | S | S | S | S | S | S | S | S | S | S | S | S | | LATE | S | S | S | S | S | S | S | S | S | S | S | S | | HLA-DR | EARLY | S | S | S | S | S | S | S | S | S | S | S | S | | LATE | S | S | S | S | S | S | S | S | S | S | S | S | | CD44 | EARLY | R | R | R | R | R | R | R | R | R | R | R | R | | LATE | R | R | R | R | R | R | R | R | R | R | R | R | | CD73 | EARLY | R | R | R | R | R | R | R | R | R | R | R | R | | LATE | R | R | R | R | R | R | R | R | R | R | R | R | | CD13 | EARLY | R | H | R | H | R | R | R | R | R | R | R | R | | LATE | R | R | R | R | R | R | R | R | R | R | R | R | | CD54 | EARLY | R | R | H | R | M | M | M | M | M | M | M | M | | LATE | H | H | H | M | R | H | H | M | M | M | M | L | | CD49d | EARLY | M | M | M | M | H | M | M | M | H | L | L | L | | LATE | R | M | H | M | H | H | H | H | S | M | L | L | | CD117 | EARLY | M | H | H | M | H | H | H | H | M | H | H | H | | LATE | H | H | H | H | H | H | H | H | H | H | H | M | | ABCG2 | EARLY | S | S | S | S | S | S | S | S | S | S | S | L | | LATE | S | S | S | S | S | S | S | S | S | S | S | L | | CD166 | EARLY | R | R | R | R | R | R | R | R | R | R | R | R | | LATE | R | R | R | R | R | R | R | R | R | R | R | R | | CD106 | EARLY | L | S | S | S | S | S | S | S | S | S | S | S | | LATE | S | S | S | S | S | S | S | S | S | S | S | S |
|
|
Expression ranges: R: remarkable (>90%); H: high (75–89%); M: moderate (40–74%); L: low (11–39%); S: sparse (<10%). Early (P1, P3, and P5), late (P9, P12, P15, and P20); OF: omentum fat; SF: subcutaneous fat; BM: bone marrow; LG: low glucose; MEM: minimum essential media; KO: knock-out.
|
